Bio Pharma Dive
JULY 14, 2021
Sales of Nurtec ODT during the second quarter were double what Wall Street expected. CEO Vlad Coric explained to BioPharma Dive how the biotech did it, despite being far smaller than its chief rival.
World of DTC Marketing
JULY 14, 2021
SUMMARY: There is a talent drain at the agency and DTC levels. More experienced DTC people are being forced to retire. TV still gets the biggest share of DTC budgets, but they don’t drive brand objectives. Talented marketers don’t want a career in pharma because of the culture. Many pharma agencies have allowed and sometimes forced experienced, talented people to leave while replacing them with inexpensive unproven people, and it shows.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JULY 14, 2021
Formed around research from the Broad Institute's David Liu and Andrew Anzalone, Prime has attracted significant funding from a wide range of high-profile biotech backers.
NY Times
JULY 14, 2021
The company said it had determined that daily exposure to five Neutrogena and Aveeno sprays would not cause adverse health effects, but recalled the products out of an abundance of caution.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
JULY 14, 2021
Rival Novo Nordisk has jumped ahead in developing an injectable drug that responds to changes in blood sugar. An acquisition of Protomer Therapeutics could help Lilly close the gap.
Outsourcing Pharma
JULY 14, 2021
The two companies will work together to come up with solutions that use machine learning and artificial intelligence to help accelerate innovation in R&D.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
JULY 14, 2021
AstraZeneca and Johnson & Johnson are both exploring ways to modify their COVID-19 vaccines to minimise the risk of severe blood clotting reactions that are seen – albeit rarely – in some people receiving the jabs. At the same time, the UK’s National Institute for Health and Care excellence (NICE) is developing guidance to help doctors manage the cases of vaccine-induced immune thrombocytopenia and thrombosis (VITT) and low blood platelet counts that have been seen with the COVID-19 va
BioSpace
JULY 14, 2021
The amount is intended to support the company's growing portfolio of RNA technologies and accelerate efforts to develop various treatment approaches in the gene therapy field.
pharmaphorum
JULY 14, 2021
In this episode of Health Innovators , pharmaphorum founder Paul Tunnah interviews Jo Brewer, senior vice president of allogeneic research at UK company Adaptimmune which is transforming cancer immunotherapy with affinity enhanced T-cell receptors. Adaptimmune’s SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors.
BioSpace
JULY 14, 2021
Prenetics, which is a diagnostics and genetics testing company, will merge with Artisan Acquisition, a SPAC company backed by Adrian Cheng, chief executive officer of Hong Kong’s New World Development.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
JULY 14, 2021
James Dempsey breaks down the misconception that culture can’t be measured, and gives tips for how companies can implement a clear culture strategy. In 2014, six years after the global financial crisis forced the world’s biggest financial institutions into some serious navel gazing, the CEO of a major international bank was despairing: “We’ve put in place a best-in-class compliance system, but we can’t stop our people acting badly.
BioSpace
JULY 14, 2021
The next COVID pandemic could be prevented by using a gene drive to preemptively edit the genome of bats to prevent them from becoming hosts for coronaviruses, according to a proposal by scientists from Israel’s Interdisciplinary Center Herzelia and the National Institutes of Health.
Pharma Times
JULY 14, 2021
Funding will go towards a number of measures aimed at speeding up cancer diagnosis and treatment
pharmaphorum
JULY 14, 2021
Eli Lilly bought a stake in Protomer Technologies and its glucose-sensing insulin platform last year, and it must like what it has seen in the programme since then – it has just agreed to buy the company outright. . Pasadena, California-based Protomer is working on proteins that can sense molecular activators in the body and only become activated when needed.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
XTalks
JULY 14, 2021
In a press briefing on Monday, the World Health Organization (WHO) responded to questions about COVID-19 vaccine boosters that led to a flurry of misleading headlines in the media about the “dangers” of mixing and matching vaccines. This was exemplified in a Reuters article that carried the headline, “WHO warns against people mixing and matching COVID vaccines.
Scienmag
JULY 14, 2021
Placing a 2D Bose-Einstein condensate in the vicinity of a graphene layer confers superconductivity to the material Credit: Institute for Basic Science Superconductivity is a physical phenomenon where the electrical resistance of a material drops to zero under a certain critical temperature. Bardeen-Cooper-Schrieffer (BCS) theory is a well-established explanation that describes superconductivity in most materials. […].
XTalks
JULY 14, 2021
With many parts of the US lifting mask mandates, chewing gum sales are starting to bounce back. But is this a coincidence, or has the COVID-19 pandemic impacted gum sales for the worst? According to NeilsonIQ data shared by Bloomberg , the correlation is present and the revival comes after two consecutive years of declining gum sales in the 12 months ending in May.
Scienmag
JULY 14, 2021
Presented by the American Federation for Aging Research (AFAR) Credit: image courtesy of UW Medicine New York, NY – The American Federation for Aging Research (AFAR), a national non-profit organization whose mission is to support and advance healthy aging through biomedical research, is proud to recognize the outstanding contributions of Andrea Gilmore-Bykovskyi, PhD, RN, with […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
BioSpace
JULY 14, 2021
Biogen’s controversial Alzheimer’s drug Aduhelm (aducanumab) is facing yet another obstacle as at least six affiliates of Blue Cross Blue Shield likely won’t cover the drug.
Scienmag
JULY 14, 2021
Credit: The University of Texas at Austin Urea is a critical element found in everything from fertilizers to skin care products. Large-scale production of urea, which is naturally a product of human urine, is a massive undertaking, making up about 2% of global energy use and emissions today. For decades, scientists and engineers have sought […].
BioSpace
JULY 14, 2021
The FDA has historically tended to keep more contentious relationships with some companies private. But recently, the agency appears to be publicly scolding some biopharma companies.
Scienmag
JULY 14, 2021
Scientists report that the alternative-splicing regulator NSrp70 influences immune T cell development Credit: Gwangju Institute of Science & Technology T lymphocytes, or T cells, are immune cells with diverse roles in building the body’s immunity. How does one particular cell type fight against a host of different pathogens? The key to this adaptability is in […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
BioSpace
JULY 14, 2021
?The CMA said some pharmaceutical firms charge the NHS with excessively high prices for hydrocortisone tablets and paid off potential competitors to stay out of the market.
Scienmag
JULY 14, 2021
Credit: (Photo by James Johnston, OSU College of Forestry) CORVALLIS, Ore. – Roadless national forests in the American West burn more often and at a slightly higher severity than national forests with roads, but the end result for the roadless forests is greater fire resilience, Oregon State University researchers say. The findings, published today in […].
Pharma Times
JULY 14, 2021
The approval is based on data from the Phase III FIDELIO-DKD renal outcomes study
Scienmag
JULY 14, 2021
Credit: Courtesy of the Max Planck Florida Institute for Neuroscience With its breathtaking views and striking stature, the Golden Gate bridge certainly deserves its title as one of the modern wonders of the world. Its elegant art deco style and iconic towers offer visitors a once-in-a-lifetime opportunity for astounding photographs. Stretching for almost 2 miles, […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Outsourcing Pharma
JULY 14, 2021
A representative from the medication management solutions company suggests patient behavior data can be used to improve adherence to trial drug regimens.
Scienmag
JULY 14, 2021
Credit: The University of Texas at Austin Hundreds of millions of people live on river deltas around the world, making them central to rich diversity in culture and thriving economies. As deltas face environmental degradation and ongoing climate change, governments have sought ever more drastic measures to prevent flooding and protect society and its infrastructure. […].
Pharma Times
JULY 14, 2021
UK approval of the acquisition comes just a week after the merger scored clearance in the EU
Scienmag
JULY 14, 2021
Researchers have found a way to enhance radiation therapy using novel iodine nanoparticles Credit: Mindy Takamiya/Kyoto University iCeMS Cancer cell death is triggered within three days when X-rays are shone onto tumor tissue containing iodine-carrying nanoparticles. The iodine releases electrons that break the tumor’s DNA, leading to cell death.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
328 
Let's personalize your content